Regulus Therapeutics
San Diego
About Regulus Therapeutics
Regulus Therapeutics Is a biopharmaceutical company leading the discovery of a new class of high-impact medicines based on microRNAs. The discovery of MicroRNA in humans is one of the most exciting scientific breakthroughs in the last decade. MicroRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteins but instead regulate gene expression. It was founded in 2007 and is headquartered in Carlsbad, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $480.9M
- Funding stage: M&A
- Last round: Post-IPO Equity (Mar 2024)
- Ticker: nasdaq:RGLS
- Website: regulusrx.com
- Phone: 858-202-6300
Industries & Categories
Biotechnology, Genetics, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/regulus-therapeutics-45052 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.